Early research (Phase 1)Looking for participantsNCT06581562
What this trial is testing
Open-label Single-Center Study to Evaluate the Safety and Efficacy of Combining Rituximab and AB-101 in B-cell Associated Autoimmune Diseases.
Who this might be right for
Rheumatoid ArthritisPemphigus VulgarisGranulomatosis With Polyangiitis+1 more
IRIS Research and Development, LLC 30